Interaction Between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism

Belkhir, Leïla; Elens, Laure; Zech, Francis; Panin, Nadtha; Yombi, Jean Cyr; Vandercam, Bernard; Haufroid, Vincent

Interaction Between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism

Belkhir, Leïla

;

Elens, Laure

;

Zech, Francis

;

Panin, Nadtha

;

Haufroid, Vincent

;et.al.

(2017) 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology — Location: (Japan) Kyoto (24.September.2017)

Files

No attached file found for this publication.

Details

Authors

Belkhir, LeïlaUCLouvain
Author
Elens, LaureUCLouvain
Author
Zech, FrancisUCLouvain
Author
Panin, NadthaUCLouvain
Author
Yombi, Jean CyrUCLouvain
Author
Vandercam, BernardUCLouvain
Author
Haufroid, VincentUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology
UCLouvainSSS/IREC/MBLG - Pôle de Microbiologie médicale
UCLouvainSSS/IREC/SLUC - Pôle St.-Luc
UCLouvain(SLuc) Service de biochimie médicale
UCLouvain(SLuc) Service de médecine interne et maladies infectieuses (MIMI)
UCLouvainSSS/LDRI - Louvain Drug Research Institute

Citations

APA
Chicago
FWB

Belkhir, L., Elens, L., Zech, F., Panin, N., Yombi, J. C., Vandercam, B., & Haufroid, V. (2017). Interaction Between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism. 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, (Japan) Kyoto. https://hdl.handle.net/2078.5/172141